Assessment of depression symptoms among cancer patients: a cross-sectional study from a developing country.

Autor: Battat M; Bone Marrow Transplant and Leukemia Unit, An-Najah National University Hospital, Nablus, 44839, Palestine., Omair N; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine., WildAli MA; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine., Alkaissi A; Department of Nursing, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine., Amer R; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine.; Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine., Koni AA; Division of Clinical Pharmacy, Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine.; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine., Salameh HT; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine. husam.salameh@najah.edu.; Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. husam.salameh@najah.edu., Zyoud SH; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. saedzyoud@yahoo.com.; Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. saedzyoud@yahoo.com.; Clinical Research Center, An-Najah National University Hospital, Nablus, 44839, Palestine. saedzyoud@yahoo.com.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2024 May 24; Vol. 14 (1), pp. 11934. Date of Electronic Publication: 2024 May 24.
DOI: 10.1038/s41598-024-62935-x
Abstrakt: Cancer patients experience psychological symptoms such as depression during the cancer treatment period, which increases the burden of symptoms. Depression severity can be assessed using the beck depression inventory (BDI II). The purpose of the study was to use BDI-II scores to measure depression symptoms in cancer patients at a large tertiary hospital in Palestine. A convenience sample of 271 cancer patients was used for a cross-sectional survey. There are descriptions of demographic, clinical, and lifestyle aspects. In addition, the BDI-II is a tool for determining the severity of depression. Two hundred seventy-one patients participated in the survey, for a 95% response rate. Patients ranged in age from 18 to 84 years, with an average age of 47 years. The male-to-female ratio was approximately 1:1, and 59.4% of the patients were outpatients, 153 (56.5%) of whom had hematologic malignancies. Most cancer patients (n = 104, 38.4%) had minimal depression, while 22.5%, 22.1%, and 17.0% had mild, moderate, and severe depression, respectively. Education level, economic status, smoking status, and age were significantly associated with depression. The BDI-II is a useful instrument for monitoring depressive symptoms. The findings support the practice of routinely testing cancer patients for depressive symptoms as part of standard care and referring patients who are at a higher risk of developing psychological morbidity to specialists for treatment as needed.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: